3-羟基噻吩-2-羧酸
|
H331929-250mg
|
|
5118-07-0 |
250mg
|
¥ 780.9
|
期货,请咨询 |
阿拉丁 |
6H-噻吩并[2,3-b]吡咯-5-羧酸
|
H331928-1g
|
≥95% |
51856-25-8 |
1g
|
¥ 5038.9
|
期货,请咨询 |
阿拉丁 |
HDSF
|
H331899-100mg
|
≥96% |
86855-26-7 |
100mg
|
¥ 5149.9
|
现货 |
阿拉丁 |
HDSF
|
H331899-25mg
|
≥96% |
86855-26-7 |
25mg
|
¥ 1715.9
|
现货 |
阿拉丁 |
3-羟基-2-(5-羟基戊基)苯并吡喃-4-酮
|
H331889-50mg
|
|
267400-83-9 |
50mg
|
¥ 1674.9
|
期货,请咨询 |
阿拉丁 |
2-(4-羟基苯基)-5-嘧啶醇
|
H331883-1g
|
≥90% |
142172-97-2 |
1g
|
¥ 377.9
|
期货,请咨询 |
阿拉丁 |
1,1,3,3,3,3-六甲基茚二碳菁碘
|
H331875-25mg
|
|
36536-22-8 |
25mg
|
¥ 657.9
|
期货,请咨询 |
阿拉丁 |
2'-羟基-5'-硝基六癸酰胺
|
H331872-100mg
|
|
60301-87-3 |
100mg
|
¥ 1535.9
|
期货,请咨询 |
阿拉丁 |
己基硼酸频哪醇酯
|
H331845-1g
|
≥97% |
86308-26-1 |
1g
|
¥ 33.9
|
现货 |
阿拉丁 |
HLI 373
|
H331805-50mg
|
≥98% |
502137-98-6 |
50mg
|
¥ 4832.9
|
期货,请咨询 |
阿拉丁 |
HLI 373
|
H331805-10mg
|
≥98% |
502137-98-6 |
10mg
|
¥ 1568.9
|
期货,请咨询 |
阿拉丁 |
己基溴化锌溶液
|
H331802-50ml
|
|
124397-96-2 |
50ml
|
¥ 1348.9
|
期货,请咨询 |
阿拉丁 |
7-十六烷基-1-醇
|
H331738-250mg
|
|
822-21-9 |
250mg
|
¥ 1918.9
|
期货,请咨询 |
阿拉丁 |
2-羟基-10,11-二氢-5H-二苯并[A,D] [7]环五酮
|
H331701-5g
|
≥97% |
17910-73-5 |
5g
|
¥ 698.9
|
现货 |
阿拉丁 |
2-羟基-10,11-二氢-5H-二苯并[A,D] [7]环五酮
|
H331701-1g
|
≥97% |
17910-73-5 |
1g
|
¥ 226.9
|
现货 |
阿拉丁 |
2-(2-羟基-1,1,1,3,3,3-六氟丙基)-1-萘酚
|
H331694-5g
|
|
2092-87-7 |
5g
|
¥ 2372.9
|
期货,请咨询 |
阿拉丁 |
2-(2-羟基-1,1,1,3,3,3-六氟丙基)-1-萘酚
|
H331694-1g
|
|
2092-87-7 |
1g
|
¥ 1012.9
|
期货,请咨询 |
阿拉丁 |
CAY10603
|
H331683-1mg
|
Moligand™, ≥98% |
1045792-66-2 |
1mg
|
¥ 448.9
|
现货 |
阿拉丁 |
H-L-Arg-Pro-pNA
|
H331641-250mg
|
|
112898-06-3 |
250mg
|
¥ 6763.9
|
期货,请咨询 |
阿拉丁 |
H-L-Arg-Pro-pNA
|
H331641-50mg
|
|
112898-06-3 |
50mg
|
¥ 1702.9
|
期货,请咨询 |
阿拉丁 |
H-β-丙氨酸-pNA HBr
|
H331631-5g
|
|
111196-17-9 |
5g
|
¥ 3731.9
|
期货,请咨询 |
阿拉丁 |
H-β-丙氨酸-pNA HBr
|
H331631-1g
|
|
111196-17-9 |
1g
|
¥ 3424.9
|
期货,请咨询 |
阿拉丁 |
1-(4-羟苯基)吡咯烷-2-酮
|
H331599-1g
|
|
7517-07-9 |
1g
|
¥ 2329.9
|
期货,请咨询 |
阿拉丁 |
哈巴苷
|
H331596-5mg
|
≥98% |
6926-08-5 |
5mg
|
¥ 204.9
|
现货 |
阿拉丁 |